MUSTOPHORAN IN THE TREATMENT OF MALIGNANT GLIOMAS: RESULTS OF PROSPECTIVE PILOT STUDY


Cite item

Full Text

Abstract

The article presents results of study involving 32 patients with malignant gliomas, which has evaluated two regimen of chemotherapy: fotemustin (Mustophoran) as monotherapy in patients with anaplastic gliomas, and Mustophoran in combination with carboplatin and etoposide in patients with glioblastoma; hematological and other toxicity of chemotherapy regimens were also assessed. Based on these results, Mustophoran as monotherapy can be recommended as a priority regimen in the adjuvant treatment of patients with anaplastic gliomas III malignance grade.

References

  1. Levin VA, Gutin PH, Leibel S. Neoplasms of the central nervous system, in Devita VT, Helman S, Rasenberg SA (eds.): Cancer Principles and Practice of Oncology, 4th Ed. Philadelphia, JB Lippin cott, 1992.
  2. Fine HA. The basis of current treatment recommendations for malignant gliomas. J Neuro-oncology 1994;20:111-20.
  3. Macdonald DR, Cascino TL, Schold SC Jr., et al. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-80.
  4. Frenay M, Giroux B, Khoury S, et al. Phase II study of a new nitrosourea, fotemustine, in recurrent malignant supratentorial gliomas. Eur J Cancer 1991;27:852-56.
  5. Mousseau M, Swiercz P, Rougny M, et al. Fotemustine in recurrent malignant glioma.
  6. Crisoli F, Namer M, Bourdin S, et al. Clinical activity of the nitrosourea fotemustine in the treatment of malignant gliomas. Ann Oncol 1990;1(Suppl.):124.
  7. Priou F, Martin S, Bourdin S, et al. Survival Analysis in a Series of 101 Glioblastoma (GBM) Treated by Surgery and Fotemustine Chemotherapy (CT) Before Radiotherapy (RT) in a Single Center. (Meeting abstract). 1999 ASCO Annual Meeting. Abstr No 587.
  8. Frenay M, Lebrun, Bondiau PY, et al. Fotemustine(F)/Cisplatin(CDDP)/Etoposide(VP16) combination in the treatment of 50 glioblastomas (gb). comparison between neoadjuvant and recurrence regimens (Meeting abstract). 1999 ASCO Annual Meeting. Abstr No 575.
  9. Yaman F, Altyn M, Altyn S, et al. Continuous hyperfractionated accelerated radiation therapy (chart) with fotemustine for malignant gliomas. Proc Am Soc Clin Oncol 2001;20:abstr. 2056.
  10. Altinbas M, Ozkan M, Er O, et al. Adjuvant radiotherapy and fotemustine in treatment of anaplastic astrocytoma and glioblastoma multiforme patients. Proc Am Soc Clin Oncol 2003;22:abstr. 459.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies